September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
An assessment of the angiogenic effects of VEGF-A and ANGPTL4 in the mouse retina.
Author Affiliations & Notes
  • Rajeevalochan wudali
    Ophthalmology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Eunice Cheung
    Ophthalmology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Angela Sun
    Ophthalmology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Laura Winters
    Oncology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Frank Kuhnert
    Oncology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Stanley J Wiegand
    Ophthalmology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Jingtai Cao
    Ophthalmology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Gavin Thurston
    Oncology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Carl Romano
    Ophthalmology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Ivan B Lobov
    Ophthalmology, Regeneron Pharmaceuticals Inc., Tarrytown, New York, United States
  • Footnotes
    Commercial Relationships   Rajeevalochan wudali, Regeneron Pharmaceuticals Inc. (E); Eunice Cheung, Regeneron Pharmaceuticals Inc. (E); Angela Sun, Regeneron Pharmaceuticals Inc. (E); Laura Winters, Regeneron Pharmaceuticals Inc. (E); Frank Kuhnert, Regeneron Pharmaceuticals Inc. (E); Stanley Wiegand, Regeneron Pharmaceuticals Inc. (E); Jingtai Cao, Regeneron Pharmaceuticals Inc. (E); Gavin Thurston, Regeneron Pharmaceuticals Inc. (E); Carl Romano, Regeneron Pharmaceuticals Inc. (E); Ivan Lobov, Regeneron Pharmaceuticals Inc. (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 121. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Rajeevalochan wudali, Eunice Cheung, Angela Sun, Laura Winters, Frank Kuhnert, Stanley J Wiegand, Jingtai Cao, Gavin Thurston, Carl Romano, Ivan B Lobov; An assessment of the angiogenic effects of VEGF-A and ANGPTL4 in the mouse retina.
      . Invest. Ophthalmol. Vis. Sci. 2016;57(12):121.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : To investigate the effects of VEGF-A and ANGPTL4 on retinal angiogenesis and blood vessel leak.

Methods : Adult (>8 week old) C57Bl/6 mice were injected intravitreally with VEGF-A or ANGPTL4 and the effects were monitored 24, 48 and 72 hours post-injection using FA and OCT (IFO). In the Oxygen-Induced Retinopathy (OIR) model, neonatal (P6) C57Bl/6 pups maintained at high oxygen environment (75% O2) for 5 days till P11 were injected systemically with 25 mg/kg of control hFc protein or ANGPTL4 at P12. Eyes from these mice were harvested at P16, retinas were dissected, stained using GS Lectin-I, imaged and analyzed. In another set of experiments, the effects of ANGPTL4 on Human Umbilical Vein Endothelial Cell (HUVEC) sprouting were assessed in the fibrin bead assay.

Results : Intravitreal injections of VEGF-A rapidly produced significant leak that persisted for at least 48 hours while intravitreal injections of ANGPTL4 had no effect on blood vessel leak. To test if the described pro-angiogenic effect of ANGPTL4 requires pre-activation of the endothelium with VEGF-A, the two proteins were injected sequentially. First, VEGF-A was injected alone and 48 hours later, ANGPTL4 was injected into the same eye. However even in these experiments ANGPTL4 did not show any additional pro-angiogenic effect.

In the OIR model, ANGPTL4 did not show any effect on the normal and pathological angiogenesis.

In the fibrin bead assay model, VEGF produced a robust cell sprouting response, while ANGPTL4 did not induce endothelial cell sprouting. Additionally, ANGPTL4 did not inhibit VEGF-induced endothelial cell sprouting, while the VEGF blocker aflibercept quantitatively suppressed the endothelial cell sprouting response.

Conclusions : VEGF-A injection induced retinal blood leak 24 hours post-injection, which started to decrease by 48 hours and disappeared almost completely by 72 hours. VEGF-A also induced endothelial cell sprouting. Despite the published data, no angiogenic effect of ANGPTL4 was observed in all these experiments. The procedural differences that may explain the distinction between our results and contrary ones in the literature remain to be elucidated.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×